Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00432-015-1936-z
Published Online: 2015-02-24
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thalgott, M.
Heck, M. M.
Eiber, M.
Souvatzoglou, M.
Hatzichristodoulou, G.
Kehl, V.
Krause, B. J.
Rack, B.
Retz, M.
Gschwend, J. E.
Andergassen, U.
Nawroth, R.
Text and Data Mining valid from 2015-02-24